Treatment of fibromyalgia with cyclobenzaprine: A meta-analysis.

OBJECTIVE To systematically review the effectiveness of cyclobenzaprine in the treatment of fibromyalgia. METHODS Articles describing randomized, placebo-controlled trials of cyclobenzaprine in people with fibromyalgia were obtained from Medline, EMBase, Psyclit, the Cochrane Library, and Federal Research in Progress Database. Unpublished literature and bibliographies were also reviewed. Outcomes, including global improvement, treatment effects on pain, fatigue, sleep, and tender points over time, were abstracted. RESULTS Five randomized, placebo-controlled trials were identified. The odds ratio for global improvement with therapy was 3.0 (95% confidence interval [95% CI] 1.6-5.6) with a pooled risk difference of 0.21 (95% CI 0.09-0.34), which calculates to 4.8 (95% CI 3.0-11) individuals needing treatment for 1 patient to experience symptom improvement. Pain improved early on, but there was no improvement in fatigue or tender points at any time. CONCLUSION Cyclobenzaprine-treated patients were 3 times as likely to report overall improvement and to report moderate reductions in individual symptoms, particularly sleep.

[1]  D. Felson,et al.  A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. , 1986, Arthritis and rheumatism.

[2]  C. Wallerstein.  US tobacco firms target Asia , 1997, BMJ.

[3]  G. A. Mccain,et al.  Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study. , 1986, Arthritis and rheumatism.

[4]  G. Pasero,et al.  Evaluation of s-adenosylmethionine in primary fibromyalgia: A double-blind crossover study , 1987 .

[5]  R. Lew,et al.  A placebo controlled crossover trial of subcutaneous salmon calcitonin in the treatment of patients with fibromyalgia. , 1998, Scandinavian journal of rheumatology.

[6]  Lewis E. Kazis,et al.  Effect Sizes for Interpreting Changes in Health Status , 1989, Medical care.

[7]  R. Marcolongo,et al.  Tramadol in the fibromyalgia syndrome: a controlled clinical trial versus placebo. , 1998, International journal of clinical pharmacology research.

[8]  D. Felson,et al.  A prospective long-term study of fibromyalgia syndrome. , 1996, Arthritis and rheumatism.

[9]  L. Leventhal.  Management of Fibromyalgia , 1999, Annals of Internal Medicine.

[10]  J. Valentine,et al.  The plasma endorphin, prostaglandin and catecholamine profile of patients with fibrositis treated with cyclobenzaprine and placebo: a 5-month study. , 1989, The Journal of rheumatology. Supplement.

[11]  S. Gurel,et al.  The Relationship between c-erbB-2 Oncogene Expression and Clinicopathological Factors in Gastric Cancer , 1999, The Journal of international medical research.

[12]  P. Tugwell,et al.  The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. , 1990, Arthritis and rheumatism.

[13]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[14]  R. Bennett,et al.  Health status and disease severity in fibromyalgia: results of a six-center longitudinal study. , 1997, Arthritis and rheumatism.

[15]  R. Bennett,et al.  A double blind crossover trial of prednisone versus placebo in the treatment of fibrositis. , 1985, The Journal of rheumatology.

[16]  Quimby Lg,et al.  A randomized trial of cyclobenzaprine for the treatment of fibromyalgia. , 1989 .

[17]  J. Nørregaard,et al.  A randomized controlled trial of citalopram in the treatment of fibromyalgia , 1995, Pain.

[18]  K. Oen,et al.  Variation in the CD4/non-T cell autologous mixed lymphocyte reaction with disease activity and rheumatoid factor titer in patients with juvenile rheumatoid arthritis. , 1989, The Journal of rheumatology.

[19]  N. Bellamy,et al.  Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial. , 1994, Arthritis and rheumatism.

[20]  F. Wolfe,et al.  The prevalence and characteristics of fibromyalgia in the general population. , 1995, Arthritis and rheumatism.

[21]  P. Goodnick,et al.  Psychotropic treatment of chronic fatigue syndrome and related disorders. , 1993, The Journal of clinical psychiatry.

[22]  I. Russell,et al.  Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam. A double-blind, placebo-controlled study. , 1991, Arthritis and rheumatism.

[23]  H. Moldofsky,et al.  The effects of cyclobenzaprine on sleep physiology and symptoms in patients with fibromyalgia. , 1991, The Journal of rheumatology.

[24]  R. Rosenthal.  The file drawer problem and tolerance for null results , 1979 .

[25]  R. Peto,et al.  Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.

[26]  R. Bennett,et al.  A comparison of cyclobenzaprine and placebo in the management of fibrositis. A double-blind controlled study. , 1988, Arthritis and rheumatism.

[27]  C. Schmid,et al.  A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. , 1996, Arthritis and rheumatism.

[28]  P. Keck,et al.  An open clinical trial of venlafaxine treatment of fibromyalgia. , 1998, Psychosomatics.

[29]  D. Felson,et al.  The present and future adequacy of rheumatology manpower. A study of health care needs and physician supply. , 1991, Arthritis and rheumatism.

[30]  P. Sarzi-Puttini,et al.  A Double-Blind Crossover Study of Two Cyclobenzaprine Regimens in Primary Fibromyalgia Syndrome , 1993, The Journal of international medical research.

[31]  C. Begg,et al.  Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.

[32]  F. Wolfe,et al.  A double-blind placebo controlled trial of fluoxetine in fibromyalgia. , 1994, Scandinavian journal of rheumatology.

[33]  M. Yunus,et al.  Short term effects of ibuprofen in primary fibromyalgia syndrome: a double blind, placebo controlled trial. , 1989, The Journal of rheumatology.

[34]  V. Azzolini,et al.  Double-Blind Study of 5-Hydroxytryptophan versus Placebo in the Treatment of Primary Fibromyalgia Syndrome , 1990, The Journal of international medical research.

[35]  A R Jadad,et al.  Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.

[36]  G. Rollman,et al.  Improvements in pain responsiveness in patients with fibrositis after successful treatment with amitriptyline. , 1989, The Journal of rheumatology. Supplement.